Royal Society of Chemistry Biomarkers for Traumatic Brain Injury: Volume 24 (Drug Discovery Series)

Due to injuries sustained in sports and in combat, interest in TBI has never been greater. Biomarkers for Traumatic Brain Injury will fulfil a gap in our understanding of what is occurring in the brain following injury that can subsequently be detected in biological fluids and imaging. This knowledge will be useful for all researchers and clinicians interested in the biochemical and structural sequelae underpinning clinical manifestations of TBI and help guide appropriate patient management. Current and prospective biomarkers for the assessment of traumatic brain injury (TBI), particularly mild TBI, are examined using a multidisciplinary approach involving biochemistry, molecular biology, and clinical chemistry. The book incorporates presentations from outstanding researchers and clinicians in the area and describes advanced proteomic and degradomic technologies in the development of novel biomarker assays. For practical purposes, the focus of this volume is on detection of blood-based biomarkers to improve diagnostic certainty of mild TBI in conjunction with radiological and clinical findings. It represents contributions from internationally-recognized researchers at the forefront of traumatic brain injury many of whom are recipients of grants and contracts from the United States Department of Defense for research specifically on developing diagnostic tests for TBI. The book will be essential reading for scientists, pharmacologists, chemists, medical and graduate students. Review Edited by Neuroscientists directing brain biomarker laboratories at their respective academic medical canters, Kennesaw State and the University of Florida, along with an industry leader (the founder of Banyan Biomarkers) this book provides a summary of the latest cutting-edge research findings in the field. ...is an essential reference for investigators, graduate and medical students in the mechanisms mediating and detection of trauma related neuronal injury. It is an inspiration for clinicians to see how the groundwork is being laid toward the development of biomarkers, which could revolutionize the world of TBI.--Amy Aloysi, Icahn School of Medicine at Mount Sinai "The journal of Head Trauma Rehabilitation" From the Inside Flap Due to injuries sustained in sports and in combat, interest in traumatic brain injury (TBI) has never been greater. Biomarkers for Traumatic Brain Injury fulfils a gap in our understanding of what is occurring in the brain following injury that can subsequently be detected in biological fluids and imaging. This knowledge is useful for all researchers and clinicians interested in the biochemical and structural sequelae underpinning clinical manifestations of TBI and help guide appropriate patient management. Current and prospective biomarkers for the assessment of TBI, particularly mild TBI, are examined using a multidisciplinary approach involving biochemistry, molecular biology, and clinical chemistry. The book incorporates presentations from outstanding researchers and clinicians in the area and describes advanced proteomic and degradomic technologies in the development of novel biomarker assays. For practical purposes, the focus of this volume is on detection of blood-based biomarkers to improve diagnostic certainty of mild TBI in conjunction with radiological and clinical findings. It represents contributions from internationally-recognized researchers at the forefront of TBI many of whom are recipients of grants and contracts from the United States Department of Defense for research specifically on developing diagnostic tests for TBI. Key chapters include: the medical need for biomarkers of TBI; the role of advanced MRI findings as biomarkers of TBI; advances in the measurement of mild TBI; neurodegradomics and biomarkers for concussions; ionotropic glutamate receptors; the clinical application of early biomarkers for mild TBI; astroglial proteins as biomarkers of intracerebral haemorrhage